Tscan Therapeutics OverviewTscan Therapeutics Other Income Expense Net
Other Income/Expense Net for TCRX.
Quarterly Other Income/Expense
$473000.00
↓ 77.72% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$4.40M
↓ 46.47% YoY
Trailing 12 months ending Mar 31, 2026